Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
Casirivimab
RdRpol
Emergency use authorization Experimental Antiviral Jan/23/2023
Imdevimab
RdRpol
Emergency use authorization Experimental Antiviral Jan/23/2023
T cells
RdRpol
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/18/2023
Remdesivir
RdRpol
Approved by FDA Experimental Antiviral Jan/18/2023
Exosomal vaccine
RdRpol
Potential treatment - pre-clinical evidence Experimental Vaccine Jul/29/2022
Sotrovimab
RdRpol
Emergency use authorization Experimental Antiviral Jul/14/2022
Nirmatrelvir
RdRpol
Emergency use authorization Experimental Antiviral Jun/23/2022
Bamlanivimab
RdRpol
Potential treatment - clinical evidence Experimental Antiviral Jun/23/2022
Etesevimab
RdRpol
Potential treatment - clinical evidence Experimental Antiviral Jun/23/2022
Convalescent plasma
RdRpol
Emergency use authorization Experimental Antiviral May/16/2022
Anakinra 
RdRpol
Recommended by guidelines Used to treat other disease Other treatment Apr/11/2022
Ivermectin
RdRpol
Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/30/2022
Baricitinib
RdRpol
Emergency use authorization Used to treat other disease Other treatment Feb/03/2022
Camptothecin
RdRpol
Potential treatment - theoretical effect Natural product Antiviral Jan/31/2022
N(4)-Hydroxycytidine
RdRpol
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/26/2022
Dexamethasone
RdRpol
Emergency use authorization Used to treat other disease Other treatment Jan/21/2022
hrsACE2
RdRpol
Potential treatment - pre-clinical evidence Experimental Antiviral Dec/23/2021
Tocilizumab
RdRpol
Recommended by China's NHC Guidelines Used to treat other disease Other treatment Dec/21/2021
Methylprednisolone
RdRpol
Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/21/2021
Favipiravir
RdRpol
Potential treatment - clinical evidence Used to treat other disease Antiviral Sep/24/2021